Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12968/hmed.2018.79.11.648 | DOI Listing |
Anatol J Cardiol
March 2019
Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center; Incheon-Republic of Korea.
Br J Hosp Med (Lond)
November 2018
Attending Physician, Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Int Heart J
January 2015
Institute of Medical Science, The University of Tokyo.
Anticoagulants such as warfarin are recommended for patients with atrial fibrillation (AF) to decrease stroke risk associated with thrombus formation in the left atrium (LA). In a subgroup of patients, however, warfarin is unable to prevent LA thrombus formation at therapeutic doses. This study characterized the clinical and echocardiographic features of patients having warfarin-resistant LA thrombus.
View Article and Find Full Text PDFJ Cardiovasc Med (Hagerstown)
August 2006
Cardiology Unit, S. Orsola Hospital, Brescia, Italy.
Atrial fibrillation is the most common rhythm disturbance and can also occur in absence of true cardiac disease. However, also in these cases, it can generate left atrial appendage thrombi with systemic embolic potential. A regular and well conducted anticoagulant therapy with dicoumarol derivatives, as indicated in these patients, is not always successful.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!